Biopsies – Active Surveillance

  1. 1.1
    What is a major concern among active surveillance patients? (1:31) Patient Mark Lichty leads an active surveillance support group Published on Aug 12, 2015
  2. 1.5
    Why did you want to avoid a third biopsy? (2:18) Patient Jim Goodacre was diagnosed with prostate cancer in 2009. Published on Aug 12, 2015
  3. 1.2
    How often do TRUS “blind” biopsies miss higher grade prostate cancer? (2:42) Bela Denes, MD, is Senior Director of Director of Urology at Genomic Health, Inc. Published on Aug 12, 2015
  4. 2.1
    What are the advantages of a targeted biopsy? (1:10) Robert Princenthal, MD, is President of Rolling Oaks Radiology in California Published on Aug 12, 2015
  5. 3.1
    Does a multi-parametric MRI offer improvements over a TRUS biopsy? (1:52) Robert Princenthal, MD, is President of Rolling Oaks Radiology in California Published on Aug 12, 2015
  6. 4.3
    Why get an MRI before a biopsy? (1:32) Ferd Becker, MD, is a physician and an active surveillance patient. Published on Aug 12, 2015
  7. 1.2
    Why have a “targeted” biopsy instead of a “random” biopsy? (1:31) Patient Lyle LaRosh is President of the Informed Prostate Cancer Support Group in San Diego. Published on Aug 12, 2015
  8. 1.5
    Could you describe your experience with sepsis? (2:18) Patient Carlos Orillo survived a serious bout with sepsis. Published on Aug 12, 2015